Date Filer Title Filing Type Shares Traded Price Total Held
Mar 06, 2023
General Counsel
General Counsel Form 3 Initial Statement of Beneficial Ownership of Securities 350,000 -- --
Sep 01, 2020
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 350,000 -- 350,000
Jun 15, 2021
Chief Business Officer
Chief Business Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 400,000 -- 400,000
Jun 01, 2021
Chief Commercial Officer
Chief Commercial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 400,000 -- 400,000
Feb 15, 2023
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 490,000 -- 490,000
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Feb 15, 2023
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 591,184 -- 591,184
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 637,984 -- 988,187
Aug 23, 2018
Director, Ten Percent Owner
Director, Ten Percent Owner Form 4 Conversion of derivative security 637,984 -- 988,187

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.